🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

Caris Life Sciences Revenue

Caris Life Sciences had revenue of $275.36M in the quarter ending September 30, 2026, with 26.99% growth. This brings the company's total for the last twelve months to $1.05B, up 61.48% year-over-year. In the year 2025, Caris Life Sciences had annual revenue of $812.03M with 96.97% growth. That makes Caris Life Sciences the 7,438th largest company in the world by revenue and 1,768th in the United States.

Revenue (ttm)
$1.05B
Revenue Growth
+61.48%
P/S Ratio
4.81
Revenue / Employee
$567,784
Employees
1,846
Market Cap
5.04B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Molecular Profiling Services 766.72M 94.4%
  • Pharma Research and Development Services 45.31M 5.6%

By Geography

Chart
  • United States 801.39M 98.7%
  • International 10.64M 1.3%
Fiscal year ended Dec 31, 2025 See the full Caris Life Sciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025812.03M399.77M96.97%
Dec 31, 2024412.26M106.13M34.67%
Dec 31, 2023306.13M47.64M18.43%
Dec 31, 2022258.49M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.